User menu

Targeted radiotherapy with Y-90-DOTA-TYR3-octreotide (Y-90-SMT487; OctreoTher (TM)): A phase I study.

Bibliographic reference Valkema, R ; Jamar, François ; Pauwels, Stanislas ; Jonard, P. ; Bakker, WH ; et. al. Targeted radiotherapy with Y-90-DOTA-TYR3-octreotide (Y-90-SMT487; OctreoTher (TM)): A phase I study..In: The Journal of Nuclear Medicine, Vol. 41, no. 5, p. 111P-111P (2000)
Permanent URL http://hdl.handle.net/2078.1/62067